Samsung Biologics Acquires US-Based Human Genome Sciences Facility from GSK for $280 Million

Laura Testa Asia & Pacific Legal Chronicle
Tagged:

O’Melveny has advised Samsung Biologics. Samsung Biologics has signed a definitive agreement to acquire 100% of Human Genome Sciences from GSK for a total purchase price…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here